Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis

31 Oct 2023

Abstract excerpt

Abstract Few studies examined blood biomarkers informative of patient-reported outcome (PRO) of disability in people with multiple sclerosis (MS). We examined the associations between serum multi-protein biomarker profiles and patient-reported MS disability. In this cross-sectional study (2017–2020), adults with diagnosis of MS (or precursors) from two independent clinic-based cohorts were divided into a training...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Sclerosis Research Studies
Share to Rheumatoid Arthritis Research and Therapies
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38192492
DOI: 10.1093/braincomms/fcad300

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisPMID 38192492Read ↗

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisSemantic proximity Read ↗

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosisSemantic proximity Read ↗

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read ↗

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosisSemantic proximity Read ↗

Not all roads lead to the immune system: The Genetic Basis of Multiple Sclerosis Severity Implicates Central Nervous System and Mitochondrial InvolvementSemantic proximity Read ↗

Current status and future opportunities in modeling Multiple Sclerosis clinical characteristicsSemantic proximity Read ↗

Novel plasma and brain proteins that are implicated in multiple sclerosisSemantic proximity Read ↗

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read ↗

Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis.Semantic proximity Read ↗

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read ↗

Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosisSemantic proximity Read ↗

Multiple sclerosis: individualized disease susceptibility and therapy response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.